Adjuvant therapy using <i>ex vivo</i>-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study.

Kim, Jong Man; Cho, Sung Yoo; Rhu, Jinsoo; Jung, Miyoung; Her, Jung Hyun; Lim, Okjae; Choi, Gyu-Seong; Shin, Eui-Cheol; Hwang, Yu-Kyeong; Joh, Jae-Won

Adjuvant therapy using ex vivo-expanded allogenic natural killer cells in hepatectomy patients with hepatitis B virus related solitary hepatocellular carcinoma: MG4101 study.

Kim, Jong Man; Cho, Sung Yoo; Rhu, Jinsoo; Jung, Miyoung; Her, Jung Hyun; Lim, Okjae; Choi, Gyu-Seong; Shin, Eui-Cheol; Hwang, Yu-Kyeong; Joh, Jae-Won.

Afiliação

Kim JM; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Cho SY; Cell Therapy Research Center, GC LabCell, Yongin, Korea.
Rhu J; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Jung M; Cell Therapy Research Center, GC LabCell, Yongin, Korea.
Her JH; Cell Therapy Research Center, GC LabCell, Yongin, Korea.
Lim O; Cell Therapy Research Center, GC LabCell, Yongin, Korea.
Choi GS; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
Shin EC; Laboratory of Immunology and Infectious Diseases, Graduate School of Medical Science and Engineering, Korea Advanced Institute of Science and Technology, Daejeon, Korea.
Hwang YK; Cell Therapy Research Center, GC LabCell, Yongin, Korea.
Joh JW; Department of Surgery, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.